Cancer has become a global cause of concern. In 2022, the projected number of new cancer cases in India was 1,461,427. Approximately one in nine people in India is expected to face a cancer diagnosis during their lifetime. With the growing number of cancer cases, it is now more than important to invest in new cancer research.
Science is making new strides every day and making cancer treatment and care for patients easier and bearable, increasing the survival rates of cancer.
In a huge milestone, breaking the boundaries of Ayurveda—Body Revival, Health Reactive has become the first Ayurvedic product to conduct human clinical trials. This clinical trial is the first step towards uniting ancient Ayurvedic wisdom with modern science. This research is also important as it clinically proves Body Revival’s and Ayurveda’s potential in cancer care for breast cancer patients.
Importance of Cancer Research
The clinical trial by Health Reactive highlights the new way for cancer care. The trial was conducted at J.B. Roy State Ayurvedic Medical College & Hospital – Dept. of Health & Family Welfare (AYUSH), Govt. of W.B. The West Bengal University of Health Sciences (Affiliated). The West Bengal University of Health Sciences (Affiliated). The trial started on 1st October 2023 and lasted 11 months, ending on 30th November 2024. In the trial on breast cancer patients, it highlighted that:
- Improved Quality of Life: Patients who used Body Revival noticed an increased stamina, and overall quality of life.
- Reduce the Side Effects: Body Revival helped reduce the side effects of chemotherapy and radiotherapy, such as nausea, vomiting, weight loss and hair loss – making cancer treatment a little easier for patients.
- Safe and Reliable for use: Body Revival has been proven to be a safe and well-tolerated option, even for patients undergoing intense treatments. This finding reassures its safety and suitability for a wide range of patients.
- Recommended by Experts: The medical team involved in the trial recommended Body Revival as a safe and effective option for cancer patients.
In addition, patients saw increased levels of haemoglobin and blood platelets, highlighting that Body Revival also has immunotherapy properties. It is a safe alternative that can complement conventional cancer treatments.
Body Revival Clinical Trial in Media
The clinical trial is big news as it is the first in India to scientifically prove that Ayurveda can help in breast cancer care. Major media houses like Dainik Bhaskar, Press Trust of India, and Hindustan Express covered it.
It was also presented at the 10th World Ayurveda Congress held from 12th December 2024 to 15th December 2024 in Dehradun. The researchers conducted the clinical trial on 44 breast cancer patients who had undergone chemotherapy and radiotherapy. They carefully controlled and monitored the trial, ensuring zero dropouts.
Body Revival was designed using carefully selected Ayurvedic herbs, which aim at helping the body recover strength and deal with the challenges of cancer treatment. This clinical trial has shown that it offers hope and support to cancer patients when they need it most.
What makes Body Revival unique?
Body Revival isn’t just another ayurvedic product. It’s the result of years of research and development, rooted in the time-tested principles of Ayurveda. We have been helping cancer patients since 1996.
Body Revival contains nine ingredients: Ashwagandha, Bael, Vacha, Manjishtha, Lodhra, Chukrika, Kukrondha, Muskmelon Seeds, and Honey.
What’s Next?
While we’re thrilled with this success, we’re already looking ahead. We aim to make Body Revival and other Ayurvedic solutions more accessible, allowing more people to experience the benefits of natural healing.
We also want to inspire more collaboration between Ayurveda and modern medicine. Together, they have the power to create a future where healthcare is not just about treating illness.